
Oncocyte Corp (IMDX) Earnings Dates & Reports
Oncocyte Corp (IMDX) Most Recent Earnings
Report DateNov 10, 2022
Period EndingQ3 2022
Est. EPS-$2.20
Actual EPS-$1.60
EarningsBeat
Oncocyte Corp (IMDX) Earnings
View the latest Oncocyte Corp (IMDX) earnings report, listen to the earnings call, and analyze historical earnings performance with AI-powered insights.
Start investing in Oncocyte Corp (IMDX)
Order type
Buy in
Order amount
Est. shares
0 shares
Oncocyte Corp (IMDX) Earnings per Share (EPS) History
Signup for full accessBrowse free
Oncocyte Corp (IMDX) Latest Earnings
The value each IMDX share was expected to gain vs. the value each share gained.
Oncocyte Corp (IMDX) reported its most recent earnings on Nov 10, 2022 for Q3 2022, posting earnings per share (EPS) of -$1.60. This exceeded analysts' expectations of -$2.20 by 27.27%, marking a Beat.
For comparison, Oncocyte Corp reported EPS of -$2 in the same quarter last year.
The company is expected to announce its next earnings report on 04/03/2023, with analysts projecting an EPS of -$1.80.
Oncocyte Corp (IMDX) Earnings History
Earnings | Est. EPS | Actual EPS | Surprise | |
---|---|---|---|---|
Q4 2022Apr 3, 2023 | -$1.80 | Next earnings call Apr. 3, 2023 | ||
Q3 2022Nov 10, 2022 | -$2.20 | -$1.60 | -27.27% | |
Q2 2022Aug 10, 2022 | -$2.20 | -$2.00 | -9.09% | |
Q1 2022May 11, 2022 | -$2.40 | -$2.20 | -8.33% | |
Q4 2021Mar 10, 2022 | -$2.60 | -$1.20 | -53.85% | |
Oncocyte Corp (IMDX) Earnings Related Price Changes
Earnings announcements may impact a stock’s price. This table highlights the Oncocyte Corp’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.
Report date | Price 1D before | Price 1D after | Change |
---|---|---|---|
Nov 10, 2022 | — | — | — |
Aug 10, 2022 | — | — | — |
May 11, 2022 | — | — | — |
Mar 10, 2022 | — | — | — |
Oncocyte Corp (IMDX) Earnings FAQs
Oncocyte Corp (IMDX) last reported earnings on Nov 10, 2022 for Q3 2022, posting an EPS of -$1.60, which Beat the estimate of -$2.20 by 27.27%.
For Q3 2022, Oncocyte Corp (IMDX) reported an EPS of -$1.60, exceeding analysts' estimate of -$2.20 by 27.27%.
For Q3 2022, Oncocyte Corp (IMDX) Beat expectations with an actual EPS of -$1.60 vs. an estimated EPS of -$2.20.
Following the last earnings report on Nov 10, 2022, Oncocyte Corp (IMDX)'s stock price moved — from — to —.
The next Oncocyte Corp (IMDX) earnings call is scheduled for Apr. 3, 2023, where executives will discuss financial results and outlook.